PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24985179-6	2014	RESULTS: tDCs induced by tacrolimus exhibit a typical tolerogenic phenotype, whose level of costimulatory molecules CD80, CD83, CD86 and HLA-DR is (2.95 +- 1.32)%, (2.33 +- 1.60)%, (90.02 +- 7.42)% and (91.80 +- 6.18)%, respectively.	Tacrolimus	25-35	CD80 molecule	Homo sapiens	116-120	
15241357-8	2004	RESULTS: Tacrolimus and steroid ointment induced a selective depletion of IDECs from the epidermis and reduced the expression of the costimulatory molecules CD80 and CD86.	Tacrolimus	9-19	CD80 molecule	Homo sapiens	157-161	
11174203-7	2001	Tacrolimus inhibited the expression of IL-2R (CD25) and of the costimulatory molecules CD80 (B7.1) and CD40.	Tacrolimus	0-10	CD80 molecule	Homo sapiens	87-91	
10594746-10	1999	Cyclosporin A (CsA) and FK506 slightly inhibited CD40 and B7-1 expression on Langerhans cells, but not B7-2.	Tacrolimus	24-29	CD80 molecule	Homo sapiens	58-62	
18547634-6	2008	RESULTS: Tacrolimus and TGF-beta1 act synergistically on the generation of LCs and the expression of CD40, CD80, CD86, CD83, and MHC II; stabilize TGF-beta receptor II expression; and decrease the stimulatory capacity of LCs toward T cells.	Tacrolimus	9-19	CD80 molecule	Homo sapiens	107-111